Search details
1.
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 602(7897): 503-509, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35110735
2.
Good CARMA: Turning bad tumor-resident myeloid cells good with chimeric antigen receptor macrophages.
Immunol Rev
; 320(1): 236-249, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37295964
3.
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
Haematologica
; 2024 Apr 18.
Article
in English
| MEDLINE | ID: mdl-38634143
4.
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
Am J Hematol
; 98(8): 1254-1264, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37334852
5.
Author Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 612(7941): E22, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36477542
6.
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
J Oncol Pharm Pract
; : 10781552231189199, 2023 Aug 21.
Article
in English
| MEDLINE | ID: mdl-37603585
7.
A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells.
Blood
; 135(7): 505-509, 2020 02 13.
Article
in English
| MEDLINE | ID: mdl-31703119
8.
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.
J Oncol Pharm Pract
; 28(4): 892-897, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35191732
9.
Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphoma.
Blood
; 132(10): 1022-1026, 2018 09 06.
Article
in English
| MEDLINE | ID: mdl-29925499
10.
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents.
Am J Hematol
; 95(7): 792-798, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32242967
11.
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
Clin Infect Dis
; 68(12): 2003-2009, 2019 05 30.
Article
in English
| MEDLINE | ID: mdl-30256954
12.
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(3): e76-e85, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30576834
13.
Epigenetic engineering empowers T cells.
Blood
; 139(14): 2091-2092, 2022 04 07.
Article
in English
| MEDLINE | ID: mdl-35389443
14.
Salvage therapy with basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease.
Am J Hematol
; 97(7): E273-E276, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35413140
15.
Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning.
Biol Blood Marrow Transplant
; 20(11): 1758-66, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25016197
16.
Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantation.
Leuk Lymphoma
; 65(2): 250-256, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38264905
17.
Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients.
Transplant Cell Ther
; 30(4): 415.e1-415.e16, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38242440
18.
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy.
Sci Transl Med
; 15(714): eadi1145, 2023 09 20.
Article
in English
| MEDLINE | ID: mdl-37651540
19.
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
Transplant Cell Ther
; 29(2): 113-118, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36336258
20.
Cancer Immunotherapy Beyond Checkpoint Blockade: JACC: CardioOncology State-of-the-Art Review.
JACC CardioOncol
; 4(5): 563-578, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36636439